439208147	439208147	CD	B-NP	O
|	|	NN	I-NP	O
EPSMH	EPSMH	NN	I-NP	O
|	|	NN	I-NP	O
68446510	68446510	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5619094	5619094	CD	B-NP	O
|	|	CC	I-NP	O
2/8/2006	2/8/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2006	3/18/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/4/2006	11/4/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FRYMOYER	FRYMOYER	NNP	B-NP	O
,	,	,	O	O
DARREN	DARREN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ANTICIPATED	ANTICIPATED	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
11/16/06	11/16/06	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
86-year-old	86-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ochsantal	Ochsantal	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
on	on	IN	B-PP	O
5/28/06	5/28/06	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
subacute	subacute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
bedridden	bedridden	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
ulcerations	ulceration	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
operative	operative	JJ	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
ulceration	ulceration	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
one	one	CD	I-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

upon	upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
described	describe	VBD	B-VP	O
dull	dull	JJ	B-NP	O
nonradiating	nonradiating	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
and	and	CC	I-NP	O
OA	OA	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
colchicine	colchicine	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
angio	angio	NN	I-NP	O
x2	x2	CD	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
in	in	IN	B-PP	O
2006	2006	CD	B-NP	O
and	and	CC	O	O
angioplasty	angioplasty	JJ	B-ADJP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
peroneal	peroneal	JJ	I-NP	O
artery	artery	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
tibioperoneal	tibioperoneal	JJ	B-NP	O
trunk	trunk	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
above-knee	above-knee	JJ	I-NP	O
popliteal	popliteal	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
angioplastied	angioplastie	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Transurethral	Transurethral	JJ	B-NP	O
resection	resection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O
,	,	,	O	O
appendectomy	appendectomy	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NN	B-NP	O
,	,	,	I-NP	O
diabetes	diabetes	NN	I-NP	O
and	and	CC	I-NP	O
brother	brother	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
42	42	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
93	93	CD	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
112/68	112/68	CD	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
has	have	VBZ	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
extending	extend	VBG	B-VP	O
midway	midway	NN	B-NP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Irregular	Irregular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Nontender	Nontender	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
radial	radial	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
dressing	dressing	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
boot	boot	NN	I-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
strength	strength	NN	I-NP	O
is	be	VBZ	B-VP	O
5/5	5/5	CD	B-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
PRESENTATION	PRESENTATION	NNP	I-NP	O
:	:	:	O	O
K	K	NN	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
30	30	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sugar	sugar	NN	B-NP	O
117	117	CD	I-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
11.3	11.3	CD	I-NP	I-protein
,	,	,	I-NP	O
30.6	30.6	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
421	421	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
2.2	2.2	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
:	:	:	O	O
CK	CK	NN	B-NP	B-protein
21	21	CD	I-NP	I-protein
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
1.4	1.4	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

IMAGING	IMAGING	NNP	B-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
increased	increase	VBD	B-VP	O
vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
digitalis	digitalis	NN	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
cared	care	VBN	I-VP	O
for	for	IN	B-PP	O
until	until	IN	B-PP	O
1/15/06	1/15/06	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
lasix	lasix	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
I/O	I/O	NN	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
and	and	CC	I-NP	O
metoprolol	metoprolol	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
event	event	NN	I-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
negative	negative	JJ	I-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Colace	Colace	NNP	B-NP	O
,	,	,	I-NP	O
Senna	Senna	NNP	I-NP	O
and	and	CC	I-NP	O
MiraLax	MiraLax	NNP	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
two	two	CD	B-NP	O
views	view	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
.	.	.	O	O

Recommended	Recommend	VBN	B-NP	O
Tylenol	Tylenol	NN	I-NP	O
,	,	,	O	O
opioids	opioid	NNS	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
continued	continued	JJ	B-NP	O
colchicine	colchicine	NN	I-NP	O
.	.	.	O	O

Intraarticular	Intraarticular	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
were	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
deferred	defer	VBN	B-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	B-DNA
I	I	NNP	I-NP	I-DNA
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
tamsulosin	tamsulosin	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
BPH	BPH	NN	I-NP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
hematologic	hematologic	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
planned	plan	VBN	I-NP	O
Plastic	Plastic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
intervention	intervention	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
several	several	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
vitamin	vitamin	NN	I-NP	O
K	K	NN	I-NP	O
preoperatively	preoperatively	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
brought	bring	VBD	B-VP	O
his	his	PRP$	B-NP	O
INR	INR	NNP	I-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.3	1.3	CD	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
on	on	IN	B-PP	O
1/15/06	1/15/06	CD	B-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Rochat	Rochat	NNP	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
Achilles	Achilles	NNP	I-NP	O
ulceration	ulceration	NN	I-NP	O
and	and	CC	I-NP	O
split	split	NN	I-NP	O
thickness	thickness	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Plastic	Plastic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postop	postop	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
elected	elect	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
inject	inject	VB	I-VP	O
steroids	steroid	NNS	B-NP	O
intraarticularly	intraarticularly	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
enough	enough	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
.	.	.	O	O

POSTOPERATIVE	POSTOPERATIVE	NNP	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
Neurologically	Neurologically	RB	B-ADVP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
p.r.n.	p.r.n.	FW	B-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
and	and	CC	I-NP	O
Zoloft	Zoloft	NN	I-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	I-NP	O
metoprolol	metoprolol	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
after	after	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
on	on	IN	B-PP	O
5/12/06	5/12/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
excessive	excessive	JJ	B-NP	O
beta	beta	NN	I-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
his	his	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Respiratory	Respiratory	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
saturating	saturate	VBG	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
without	without	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
tolerating	tolerate	VBG	I-VP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
5/12/06	5/12/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
voided	void	VBD	B-VP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
his	his	PRP$	B-NP	O
tamsulosin	tamsulosin	NN	I-NP	O
.	.	.	O	O

Hematologically	Hematologically	RB	B-ADVP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
postoperatively	postoperatively	RB	B-ADVP	O
at	at	IN	B-PP	O
27.8	27.8	CD	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
29.4	29.4	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
for	for	IN	B-PP	O
graft	graft	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
7.8	7.8	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NNP	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
titrated	titrate	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
sugars	sugar	NNS	I-NP	I-cell_type
.	.	.	O	O

His	His	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
32	32	CD	B-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
NovoLog	NovoLog	NN	B-NP	B-protein
4	4	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

Rheumatologically	Rheumatologically	RB	B-ADVP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
intraarticular	intraarticular	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
injection	injection	NN	I-NP	O
improved	improve	VBD	B-VP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
minimally	minimally	RB	B-ADVP	O
and	and	CC	I-ADVP	O
thus	thus	RB	I-ADVP	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
planning	plan	VBG	I-VP	O
on	on	IN	B-PP	O
injection	injection	NN	B-NP	O
of	of	IN	B-PP	O
Synvisc	Synvisc	NN	B-NP	O
intraarticularly	intraarticularly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
-LRB-	-LRB-	NN	B-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
OA	OA	NN	I-NP	O
,	,	,	O	O
gouty	gouty	NN	B-NP	B-protein
changes	change	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
dressings	dressing	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
down	down	RP	B-PRT	O
on	on	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
taking	take	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
donor	donor	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
receiving	receive	VBG	I-VP	O
heat	heat	NN	B-NP	O
lamp	lamp	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
mobility	mobility	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
limited	limit	VBN	I-VP	O
significantly	significantly	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-protein
severe	severe	JJ	I-NP	I-protein
right	right	JJ	I-NP	I-protein
knee	knee	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapist	therapist	NN	I-NP	O
will	will	MD	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
dressings	dressing	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
taken	take	VBN	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
UPON	UPON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
resting	rest	VBG	I-VP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
he	he	PRP	B-NP	O
attempts	attempt	VBZ	B-VP	O
to	to	TO	I-VP	O
move	move	VB	I-VP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
is	be	VBZ	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
superiorly	superiorly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
slightly	slightly	RB	I-ADVP	O
decreased	decrease	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
donor	donor	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
Xeroform	Xeroform	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
Xeroform	Xeroform	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
is	be	VBZ	B-VP	O
swollen	swell	VBN	I-VP	O
and	and	CC	O	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
passive	passive	JJ	B-NP	O
and	and	CC	I-NP	O
active	active	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Acetaminophen	Acetaminophen	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
tamsulosin	tamsulosin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
32	32	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
a.c.	a.c.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

P.r.n.	P.r.n.	NN	B-NP	O
meds	med	NNS	I-NP	O
include	include	VBP	B-VP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Maalox	Maalox	NN	B-NP	O
1-2	1-2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mammoccio	Mammoccio	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
INRs	INR	NNS	I-NP	B-protein
checked	check	VBD	B-VP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
heat	heat	NN	B-NP	O
lamp	lamp	NN	I-NP	O
treatment	treatment	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
split	split	JJ	I-NP	O
thickness	thickness	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
donor	donor	NN	I-NP	O
site	site	NN	I-NP	O
20	20	CD	B-NP	O
minutes	minute	NNS	I-NP	O
t.i.d.	t.i.d.	VBN	B-VP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
Xeroform	Xeroform	NN	I-NP	O
falls	fall	VBZ	B-VP	O
off	off	RP	B-PRT	O
.	.	.	O	O

The	The	DT	B-NP	O
split	split	JJ	I-NP	B-DNA
thickness	thickness	NN	I-NP	I-DNA
skin	skin	NN	I-NP	I-DNA
graft	graft	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
should	should	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
Xeroform	Xeroform	NNP	B-NP	O
and	and	CC	I-NP	O
Kerlix	Kerlix	NNP	I-NP	O
dressing	dress	VBG	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
while	while	IN	B-SBAR	O
inpatient	inpatient	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
receive	receive	VB	I-VP	O
his	his	PRP$	B-NP	O
MR	MR	NN	I-NP	B-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
MRI	MRI	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
refer	refer	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
for	for	IN	B-PP	O
final	final	JJ	B-NP	O
details	detail	NNS	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
final	final	JJ	I-NP	O
list	list	NN	I-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
plans	plan	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
MRI	MRI	NN	B-NP	B-protein
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-5549456	0-5549456	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BRECHBILL	BRECHBILL	NNP	B-NP	O
,	,	,	O	O
WOODROW	WOODROW	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CAMBERO	CAMBERO	NNP	B-NP	O
,	,	,	O	O
CYRIL	CYRIL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1033255	1033255	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/16/06	11/16/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/16/06	11/16/06	CD	B-NP	O

